Pluri Inc.

Regulatory Filings • Dec 10, 2007

8-A12B 1 v096772_8ka.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-A

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR 12(g) OF THE

SECURITIES EXCHANGE ACT OF 1934

PLURISTEM THERAPEUTICS INC.

(Exact name of registrant as specified in its charter)

Delaware	98-0351734
(State
of incorporation or organization)	(I.R.S.
Employer Identification No.)
MATAM
Advanced Technology Park, Building
No. 20, Haifa, Israel	31905
(Address
of principal executive offices)	(Zip
Code)

| Title
of Each Class | Name
of Each Exchange on Which |
| --- | --- |
| to
be so Registered | Each
Class is to be Registered |
| Common
Stock, par value $0.00001 per share | The
NASDAQ Stock Market LLC |

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. [X]

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A. (d), check the following box. [ ]

Securities Act registration statement file number to which this form relates: N/A (if applicable)

Securities to be registered pursuant to Section 12(g) of the Act: None

(Title of class)

Common Stock, $0.00001 par value per share.

(Title of class)

ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED .

The Company's authorized common stock consists of 7,000,000 shares with a par value of $0.00001 per share. All shares have equal voting rights and are entitled to one vote per share in all matters to be voted upon by stockholders. The shares have no pre-emptive, subscription, conversion or redemption rights and may be issued only as fully paid and non-assessable shares. Holders of the common stock are entitled to equal ratable rights to such dividends and distributions with respect to the common stock as may be declared by the Board of Directors out of funds legally available.

.

ITEM 2. EXHIBITS .

Exhibit	Description
3.1	Articles
of Incorporation (incorporated by reference from the Company’s
registration statement on Form SB-2 filed September 10, 2001).
3.2	Amended
By-laws (incorporated by reference from the Company’s Current Report on
Form 8-K filed January 22, 2007)

SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized.

| PLURISTEM
THERAPEUTICS INC. | |
| --- | --- |
| By: | /S/
Zami Aberman |
| | Zami
Aberman |
| | Chief
Executive Officer |

Date: December 10, 2007